Latest filing published 15 Dec 2025 for Ultralife CORP, €8,519.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +6.7%Entry US$5.79 · Close 22 Oct 2026 US$6.18
- -18.8%Entry US$8.13 · Close at T+365 US$6.60
- -27.9%Entry US$10.92 · Close at T+365 US$7.87
- -6.1%Entry US$9.97 · Close at T+365 US$9.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Janie Goddard: trading record in brief
Janie Goddard (board member) discloses dealings in 3 companies, chiefly Methode Electronics Inc, Ultralife Corp and ESS Tech, Inc. In total, 22 filings cover trades dated from 7 July 2021 to 15 December 2025.
Purchases make up the whole of the open-market record (4 purchases, €47k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 17 share grants. In 2025 alone, the filings show 2 purchases and no sales.
The median purchase comes to €12k. Of 4 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 25% of cases; the median change was -15.6%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 15 December 2025, the filings show an open-market purchase worth €8,519 in Ultralife Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Janie Goddard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,739 shares@ US$5.7518.0% of flowCommon Stock; $.10 par valueSEC:0001437749-25-037844:0Canonical exit: 15 Mar 2026 (T+90)
- 264.49 shares@ US$6.330.3% of flowPhantom StockSEC:0000950170-25-102146:0
- 1,548 shares@ US$7.6821.7% of flowCommon Stock; $.10 par valueSEC:0001437749-25-020305:0Canonical exit: 11 Sept 2025 (T+90)
- 490.97 shares@ US$6.680.5% of flowPhantom StockSEC:0000950170-25-064719:0
- 286.19 shares@ US$11.320.6% of flowPhantom StockSEC:0000950170-25-013842:0
- 353.28 shares@ US$9.030.5% of flowPhantom StockSEC:0000950170-24-121670:0
- 245.21 shares@ US$12.870.5% of flowPhantom StockSEC:0000950170-24-088093:0
- 14,170 shares@ US$9.8824.3% of flowPhantom StockSEC:0000950170-24-074348:0
- 1,397 shares@ US$10.9129.6% of flowCommon Stock; $.10 par valueSEC:0001437749-24-019604:0Canonical exit: 5 Sept 2024 (T+90)
- 94.83 shares@ US$12.220.2% of flowPhantom StockSEC:0000950170-24-050724:0
- 54.09 shares@ US$21.280.2% of flowPhantom StockSEC:0000950170-24-008998:0
- 50.38 shares@ US$22.710.2% of flowPhantom StockSEC:0001209191-23-053978:0
- 1,500 shares@ US$10.3630.6% of flowCommon Stock; $.10 par valueSEC:0001437749-23-025661:0Canonical exit: 10 Dec 2023 (T+90)
- 34.83 shares@ US$32.710.2% of flowPhantom StockSEC:0001209191-23-044055:0
- 4,201 shares@ US$33.3324.1% of flowPhantom StockSEC:0001209191-23-041847:0
- 13.4 shares@ US$40.990.1% of flowPhantom StockSEC:0001209191-23-026564:0
- 11.66 shares@ US$46.970.1% of flowPhantom StockSEC:0001209191-23-005732:0
- 13.33 shares@ US$40.940.1% of flowPhantom StockSEC:0001209191-22-055067:0
- 13.19 shares@ US$41.240.1% of flowPhantom StockSEC:0001209191-22-043976:0
- 3,885 shares@ US$36.0425.7% of flowPhantom StockSEC:0001209191-22-041812:0
- 50,000 sharesCommon StockSEC:0000899243-21-040099:0
- 2,955 shares@ US$47.3922.2% of flowCommon StockSEC:0001209191-21-046215:0
22 of 22 declarations